A meta-analysis had evaluated the impact of CASC9 on the prognosis and clinicopathological features of patients with cancer, found that a higher CASC9 signified a severe invasion, and high CASC9 meant lower overall survival rate [21]. This evidence concerns the gene CASC9 and cancer.